TabletAnti Viral Anti Hepatitis

Daclatasvir Tablets

Daclatasvir · NS5A inhibitor direct-acting antiviral

TabletAnti Viral Anti Hepatitis

Daclatasvir TabletsProspero Healthcare

This tablet contains Daclatasvir and belongs to the group of NS5A inhibitor direct-acting antiviral products. It is used in the management of chronic hepatitis C virus infection, in line with standard clinical indications for this class.

Uses

Chronic hepatitis C virus infection

Enquire about this product

Specifications are indicative; availability, composition, pack sizes and registration requirements may vary by destination market.

01Specification

Product details

Composition: Daclatasvir
Available strengthsIndicative: 30 mg · 60 mg
Dosage form: Tablet
Therapeutic category: Anti Viral Anti Hepatitis
Therapeutic class: NS5A inhibitor direct-acting antiviral
Packing: 10 × 10 tablets in blister / Alu-Alu strips
Storage: Store below 30 °C, protected from light and moisture.

02Related

From the same category

View the category